![Kathleen Gogas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kathleen Gogas
Nessuna posizione attualmente
Profilo
Kathleen Gogas worked as Vice President-Preclinical Development at Symic Bio, Inc. before obtaining a doctorate degree from Albany Medical College.
Precedenti posizioni note di Kathleen Gogas
Società | Posizione | Fine |
---|---|---|
Symic Bio, Inc.
![]() Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Kathleen Gogas
Albany Medical College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Symic Bio, Inc.
![]() Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Kathleen Gogas